Medical and Regulatory Affairs
The regulatory environments within the industry continue to change and vary internationally. Our regulatory and medical professionals keep track of the changes and anticipate developments globally.

We provide expertise either as an independent team or working alongside the client’s own management from early stage research through to product launch.

Chiltern’s contribution to projects can range from the strategic planning of critical paths to applying for clinical trial and marketing authorizations. We have extensive experience in providing due diligence programs and full pharmacovigilance services for licensed and unlicensed products.

The knowledge base within Chiltern’s Regulatory and Medical Affairs Team ensures that studies have consistent high standards of scientific and medical representation to meet the requirements of the relevant competent authorities. Customized seminars are also available to provide valuable training to client in-house teams.

For more information about our capabilities, please click on the links below.
In The Media
Chiltern Announces Senior Appointments Aimed at Securing the Company's Continued Success and Future Growth, 13 May 2013 More
Chiltern Announces the Promotions of Stuart McGuire and Jim Szymeczek, 25 March 2013 More
SOTIO a.s. Appoints Chiltern International, 18 March 2013 More
Chiltern Wins CRO Leadership Award from Life Science Leader, 11 March 2013 More
Chiltern Wins PharmaTimes Award, 4 February 2013 More